bacteri
mening
infecti
diseas
high
rate
mortal
sever
sequela
earli
identif
caus
bacteri
viral
pathogen
import
enabl
prompt
appropri
treatment
therebi
prevent
lifethreaten
clinic
outcom
patient
suspect
mening
gener
prescrib
antibiot
hospit
admiss
cerebrospin
fluid
csf
collect
examin
howev
administr
antibiot
may
render
difficult
cultur
caus
bacteria
therebi
impair
microbiolog
diagnosi
counter
problem
altern
method
molecular
identif
includ
rrna
gene
amplif
follow
sequenc
realtim
pcr
develop
howev
clinic
applic
techniqu
limit
presenc
interf
bacteri
viral
dna
timeconsum
natur
assay
small
number
detect
channel
avail
realtim
pcr
platform
limit
overcom
use
multiplex
pcr
method
enabl
rapid
accur
identif
bacteri
viral
pathogen
clinic
sampl
evalu
diagnost
valu
newli
develop
seeplex
mening
ace
detect
kit
seegen
inc
seoul
korea
multiplex
pcr
kit
use
dual
prime
oligonucleotid
dpo
method
kit
detect
common
bacteri
viral
pathogen
acut
mening
name
streptococcu
pneumonia
sp
haemophilu
influenza
hi
neisseria
meningitidi
nm
group
b
streptococci
gb
listeria
monocytogen
lm
herp
simplex
viru
hsv
varicellazost
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
herp
viru
human
enteroviru
hev
seeplex
mening
ace
detect
kit
compon
seeplex
meningitisb
detect
bacteria
sp
hi
type
b
nm
gb
lm
seeplex
detect
virus
vzv
ebv
cmv
seeplex
detect
hev
seeplex
meningitisb
assay
amplifi
dna
wherea
seeplex
assay
amplifi
cdna
reversetranscrib
viral
rna
target
gene
amplifi
strain
shown
tabl
pcr
amplif
perform
use
isol
nucleic
acid
solut
mixtur
master
mix
seegen
inc
total
volum
amplif
protocol
follow
initi
denatur
min
cycl
denatur
sec
anneal
sec
extens
sec
amplifi
pcr
product
electrophores
wv
agaros
gel
stain
ethidium
bromid
pcr
product
clone
vector
size
bp
clone
plasmid
harvest
dna
concentr
measur
number
target
copi
calcul
dna
unit
equal
copi
sensit
system
evalu
amplifi
serial
dilut
plasmid
concentr
distil
water
neg
control
sampl
pcramplifi
electrophores
wv
agaros
gel
analyt
sensit
defin
lowest
templat
copi
number
amplifi
product
consist
detect
triplic
sampl
refer
strain
use
bacteria
virus
follow
sp
atcc
hi
atcc
nm
atcc
gb
atcc
lm
atcc
cmv
atcc
ebv
korean
isol
atcc
atcc
vzv
korean
isol
korean
isol
hev
atcc
primer
specif
assess
evalu
crossreact
human
genom
dna
refer
strain
includ
hev
speci
tabl
june
novemb
clinic
csf
sampl
collect
patient
women
men
diagnos
acut
mening
basi
clinic
symptom
csf
find
wbc
count
distribut
lymphocyt
neutrophil
glucos
level
bacteri
mening
differenti
viral
asept
mening
wbc
count
neutrophil
domin
ratio
csf
glucoseserum
glucos
level
less
case
insignific
wbc
count
discrep
result
differ
paramet
classifi
undetermin
group
median
patient
age
yr
rang
month
yr
verif
studi
test
sampl
collect
time
diagnosi
ie
antibiot
therapi
initi
anoth
set
sampl
use
assess
discrep
posit
result
obtain
patient
sampl
bloodcolor
show
leakag
age
hr
strongli
suspect
contamin
discrep
pathogen
detect
consecut
test
exclud
sampl
assess
convent
csf
microscop
analysi
stain
cultur
control
csf
sampl
collect
patient
patient
acut
cerebr
bleed
primari
metastat
brain
tumor
tubercul
enceph
mump
cryptococcu
neoforman
infect
clinic
suspect
mening
due
candida
rickettsia
remain
patient
show
normal
find
csf
specimen
centrifug
min
dna
extract
supernat
cell
pellet
use
nucleic
acid
purif
column
accord
manufactur
instruct
qiagen
inc
valencia
ca
usa
use
directli
test
rna
also
extract
csf
supernat
cdna
synthes
revers
transcript
use
first
strand
cdna
synthesi
kit
fermenta
ontario
canada
use
test
posit
result
confirm
convent
pcr
amplif
use
singl
primer
pair
subsequ
sequenc
amplicon
purifi
use
pcr
purif
kit
solgent
daejeon
korea
sequenc
use
bigdy
termin
cycl
sequenc
kit
pe
appli
biosystem
foster
citi
ca
usa
abi
prism
dna
analyz
pe
appli
biosystem
sequenc
analyz
use
basic
local
align
search
tool
blast
provid
nation
centr
biotechnolog
inform
http
wwwncbinlmnihgovblast
detect
sensit
highest
gb
lower
limit
detect
lod
genomesml
lowest
hi
lod
genomesml
lod
hev
ebv
vzv
nm
cmv
sp
lm
genomesml
respect
analyt
sensit
target
pathogen
higher
copi
per
reaction
state
manufactur
crossreact
evid
human
genom
dna
refer
strain
seeplex
ace
detect
kit
success
differenti
hev
speci
strain
csf
sampl
obtain
patient
time
diagnosi
activ
mening
administr
antibiot
treatment
among
sampl
yield
posit
result
seeplex
kit
tabl
five
case
show
posit
result
hev
consist
result
convent
studi
howev
case
result
consist
result
convent
studi
one
posit
lm
ebv
seeplex
mening
ace
detect
kit
posit
lm
convent
studi
test
posit
hev
seeplex
mening
ace
detect
kit
posit
vzv
convent
studi
case
present
bacteri
viral
featur
respect
csf
analysi
seeplex
mening
ace
detect
kit
detect
caus
pathogen
case
test
neg
convent
studi
two
patient
singl
bacteri
infect
gb
lm
csf
analysi
reveal
bacteri
undetermin
featur
respect
singl
viral
infect
evid
patient
hev
vzv
ebv
case
posit
result
virus
show
viral
undetermin
featur
csf
analysi
five
patient
show
simultan
infect
bacteri
viral
pathogen
test
posit
sp
hev
test
posit
sp
sp
vzv
ebv
one
case
posit
sp
hev
csf
find
compat
bacteri
mening
other
featur
consist
viral
mening
lymphocyt
domin
high
glucos
level
sequenc
amplicon
show
evid
falseposit
crossreact
rate
blast
match
csf
sampl
obtain
remain
patient
test
posit
seeplex
kit
sequenti
workup
convent
studi
show
patient
infect
ebv
vzv
sp
hev
consist
csf
find
pathogen
agent
patient
could
identifi
although
csf
analysi
indic
bacteri
infect
viral
infect
remain
indetermin
find
none
control
case
show
falseposit
result
acut
mening
requir
prompt
treatment
avoid
lifethreaten
clinic
outcom
sever
sequela
sinc
variou
viral
bacteri
pathogen
caus
acut
mening
caus
agent
must
identifi
treatment
initi
convent
diagnost
tool
includ
csf
stain
cultur
antigen
analysi
limit
diagnost
sensit
specif
prompt
develop
sever
molecular
method
employ
convent
realtim
multiplex
pcr
although
previous
develop
multiplex
pcr
method
rapidli
identifi
bacteri
viral
agent
seeplex
mening
ace
detect
kit
employ
dpo
method
identifi
common
bacteri
viral
agent
caus
mening
sp
hi
nm
gb
lm
cmv
hev
ebv
vzv
dpo
consist
separ
prime
region
join
polydeoxyinosin
linker
yield
primer
segment
distinct
anneal
properti
long
initi
stabl
prime
wherea
short
control
targetspecif
extens
use
primer
segment
effect
elimin
nonspecif
prime
yield
consist
high
pcr
specif
even
lessthanoptim
pcr
condit
method
highli
appropri
identif
differenti
viral
bacteri
pathogen
variabl
genet
characterist
low
avail
primer
site
sever
multiplex
pcr
kit
use
dpo
technolog
develop
identifi
common
viral
bacteri
pathogen
caus
respiratori
infect
diarrhea
kit
current
use
clinic
laboratori
found
seeplex
mening
ace
detect
kit
offer
high
sensit
specif
identifi
bacteri
viral
pathogen
patient
diagnos
acut
mening
lod
pathogen
rang
crossreact
human
genom
dna
refer
clinic
identifi
bacteri
viral
pathogen
evid
indic
high
specif
kit
valid
studi
reveal
kit
success
identifi
pathogen
csf
sampl
collect
patient
clinic
diagnos
acut
mening
pathogen
identifi
use
seeplex
mening
ace
detect
kit
also
identifi
laboratori
method
pathogen
hev
case
lm
remain
case
six
csf
sampl
simultan
posit
pathogen
suggest
coinfect
contamin
rather
falseposit
subsequ
sequenc
pcr
product
yield
match
sequenc
blast
databas
pathogen
assay
hev
highest
preval
detect
sampl
seeplex
mening
ace
detect
kit
bacteri
strain
sp
frequent
detect
sp
detect
sampl
although
detect
along
virus
includ
hev
vzv
sampl
five
patient
whose
sampl
neg
time
diagnosi
later
found
ebv
vzv
sp
hev
infect
investig
convent
studi
discrep
perhap
attribut
interspecimen
differ
vari
stage
infect
patient
test
neg
pathogen
indetermin
csf
paramet
wherea
show
find
consist
bacteri
viral
infect
presenc
clinic
featur
mening
indetermin
csf
find
patient
may
attribut
condit
acut
viral
bacteri
mening
contrast
mening
patient
csf
find
consist
bacteri
viral
infect
may
caus
pathogen
assay
seeplex
mening
ace
detect
kit
altern
concentr
pathogen
csf
may
low
permit
detect
conclus
seeplex
mening
ace
detect
kit
show
high
sensit
specif
common
bacteri
viral
agent
caus
acut
mening
high
detect
rate
observ
csf
sampl
obtain
patient
clinic
diagnos
acut
mening
kit
may
enabl
rapid
identif
pathogen
patient
acut
mening
